QuasitHealth insurance companies in America have mostly stopped covering GLP1 drugs such as Wegovy and Ozempic •except• for people who are actually diabetic. This is due to the extremely high cost of such drugs.
This is bad for public health, since GLP1s are effective for the millions of pre-diabetic Americans with metabolic syndrome; they reduce the chance of developing Type 2 diabetes and heart disease. They are also effective weight loss drugs, which has other health benefits as well.
So once again working class Americans will pay with their lives for the greed of Big Pharma, health insurance companies, and the oligarchs.
Kotes